NasdaqGS - Delayed Quote • USD
Halozyme Therapeutics, Inc. (HALO)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 7:49 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 291,086 | 20 |
| Sales | 120,000 | 6 |
| Net Shares Purchased (Sold) | 171,086 | 26 |
| Total Insider Shares Held | 1.37M | -- |
| % Net Shares Purchased (Sold) | 14.30% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| LABARRE MICHAEL J. Chief Technology Officer | Sale at price 38.35 - 38.49 per share. | Direct | 768,390 | Apr 17, 2024 |
| LABARRE MICHAEL J. Chief Technology Officer | Conversion of Exercise of derivative security at price 8.11 per share. | Direct | 162,200 | Apr 17, 2024 |
| LABARRE MICHAEL J. Chief Technology Officer | Conversion of Exercise of derivative security at price 8.11 - 16.78 per share. | Direct | 130,160 | Mar 26, 2024 |
| LABARRE MICHAEL J. Chief Technology Officer | Sale at price 41.64 - 42.27 per share. | Direct | 839,100 | Mar 13, 2024 |
| LABARRE MICHAEL J. Chief Technology Officer | Conversion of Exercise of derivative security at price 8.11 - 12.07 per share. | Direct | 227,338 | Mar 13, 2024 |
| LABARRE MICHAEL J. Chief Technology Officer | Sale at price 39.54 - 39.95 per share. | Direct | 794,923 | Feb 28, 2024 |
| LABARRE MICHAEL J. Chief Technology Officer | Conversion of Exercise of derivative security at price 8.11 per share. | Direct | 60,590 | Feb 28, 2024 |
| LABARRE MICHAEL J. Chief Technology Officer | -- | Direct | -- | Feb 16, 2024 |
| TORLEY HELEN I Chief Executive Officer | -- | Direct | -- | Feb 16, 2024 |
| SNYDER MARK HOWARD General Counsel | -- | Direct | -- | Feb 16, 2024 |
| LABROSSE NICOLE Chief Financial Officer | -- | Direct | -- | Feb 16, 2024 |
| LABARRE MICHAEL J. Chief Technology Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 15, 2024 |
| LABARRE MICHAEL J. Chief Technology Officer | -- | Direct | -- | Feb 15, 2024 |
| TORLEY HELEN I Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 15, 2024 |
| TORLEY HELEN I Chief Executive Officer | -- | Direct | -- | Feb 15, 2024 |
| LABROSSE NICOLE Chief Financial Officer | -- | Direct | -- | Feb 15, 2024 |
| LABARRE MICHAEL J. Chief Technology Officer | -- | Direct | -- | Feb 9, 2024 |
| TORLEY HELEN I Chief Executive Officer | -- | Direct | -- | Feb 9, 2024 |
| LABROSSE NICOLE Chief Financial Officer | -- | Direct | -- | Feb 9, 2024 |
| LABARRE MICHAEL J. Chief Technology Officer | Sale at price 36.00 per share. | Direct | 720,000 | Jan 17, 2024 |
| LABARRE MICHAEL J. Chief Technology Officer | Conversion of Exercise of derivative security at price 12.07 per share. | Direct | 241,400 | Jan 17, 2024 |
| SNYDER MARK HOWARD General Counsel | -- | Direct | -- | Jan 3, 2024 |
| LABARRE MICHAEL J. Chief Technology Officer | Sale at price 39.58 - 40.47 per share. | Direct | 800,262 | Dec 13, 2023 |
| LABARRE MICHAEL J. Chief Technology Officer | Conversion of Exercise of derivative security at price 12.07 - 13.81 per share. | Direct | 256,247 | Dec 13, 2023 |
| LABARRE MICHAEL J. Chief Technology Officer | Sale at price 39.08 - 39.79 per share. | Direct | 788,670 | Nov 15, 2023 |
| LABARRE MICHAEL J. Chief Technology Officer | Conversion of Exercise of derivative security at price 13.81 - 16.78 per share. | Direct | 281,273 | Nov 15, 2023 |
| LABARRE MICHAEL J. Officer | Sale at price 36.52 per share. | Direct | 365,200 | Oct 17, 2023 |
| LABARRE MICHAEL J. Officer | Conversion of Exercise of derivative security at price 19.98 per share. | Direct | 199,800 | Oct 17, 2023 |
| LABARRE MICHAEL J. Chief Technology Officer | Sale at price 39.10 per share. | Direct | 390,980 | Sep 19, 2023 |
| LABARRE MICHAEL J. Chief Technology Officer | Conversion of Exercise of derivative security at price 19.98 per share. | Direct | 199,800 | Sep 19, 2023 |
| TORLEY HELEN I Chief Executive Officer | Sale at price 42.40 - 42.85 per share. | Direct | 1,280,730 | Aug 31, 2023 |
| TORLEY HELEN I Chief Executive Officer | Conversion of Exercise of derivative security at price 13.87 per share. | Direct | 416,100 | Aug 31, 2023 |
| LABARRE MICHAEL J. Chief Technology Officer | Sale at price 42.41 per share. | Direct | 424,070 | Aug 22, 2023 |
| LABARRE MICHAEL J. Chief Technology Officer | Conversion of Exercise of derivative security at price 18.41 - 19.98 per share. | Direct | 196,778 | Aug 22, 2023 |
| TORLEY HELEN I Chief Executive Officer | Sale at price 43.18 - 43.77 per share. | Direct | 1,304,820 | Aug 17, 2023 |
| TORLEY HELEN I Chief Executive Officer | Conversion of Exercise of derivative security at price 13.87 per share. | Direct | 416,100 | Aug 17, 2023 |
| DALY JAMES M. Director | Sale at price 43.71 - 43.74 per share. | Direct | 874,520 | Aug 14, 2023 |
| TORLEY HELEN I Chief Executive Officer | Sale at price 42.69 - 43.79 per share. | Direct | 1,292,750 | Jul 27, 2023 |
| TORLEY HELEN I Chief Executive Officer | Conversion of Exercise of derivative security at price 13.87 per share. | Direct | 416,100 | Jul 27, 2023 |
| LABARRE MICHAEL J. Officer | Sale at price 40.43 per share. | Direct | 404,300 | Jul 18, 2023 |
| LABARRE MICHAEL J. Officer | Conversion of Exercise of derivative security at price 8.11 - 18.41 per share. | Direct | 306,098 | Jul 18, 2023 |
| LABARRE MICHAEL J. Chief Technology Officer | Sale at price 36.00 per share. | Direct | 360,000 | Jun 21, 2023 |
| LABARRE MICHAEL J. Chief Technology Officer | Conversion of Exercise of derivative security at price 18.41 per share. | Direct | 184,100 | Jun 21, 2023 |
| MATSUI CONNIE L Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 5, 2023 |
| DUNCAN BARBARA GAYLE Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 5, 2023 |
| HENDERSON JEFFREY WILLIAM Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 5, 2023 |
| POSARD MATTHEW L Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 5, 2023 |
| DALY JAMES M. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 5, 2023 |
| BIZZARI JEAN-PIERRE Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 5, 2023 |
| CONNAUGHTON BERNADETTE M. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 5, 2023 |
Related Tickers
GMAB Genmab A/S
28.15
+2.51%
IONS Ionis Pharmaceuticals, Inc.
41.59
-0.60%
UTHR United Therapeutics Corporation
233.85
-0.89%
EXEL Exelixis, Inc.
23.70
+0.72%
BPMC Blueprint Medicines Corporation
93.00
+2.50%
FOLD Amicus Therapeutics, Inc.
10.28
+1.08%
INCY Incyte Corporation
51.68
+0.98%
RARE Ultragenyx Pharmaceutical Inc.
44.24
+0.89%
LEGN Legend Biotech Corporation
45.30
+1.98%
JAZZ Jazz Pharmaceuticals plc
109.46
+1.89%